SIC
RGEN icon

SJS Investment Consulting’s Repligen RGEN Stock Holding History

SJS Investment Consulting’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2
Closed -$328 – 2555
2025
Q4 		$328 Hold
2
– – ﹤0.01% 1658
2025
Q3 		$268 Hold
2
– – ﹤0.01% 1406
2025
Q2 		$249 Sell
2
-1
-33% -$127 ﹤0.01% 1316
2025
Q1 		$382 Hold
3
– – ﹤0.01% 1325
2024
Q4 		$432 Hold
3
– – ﹤0.01% 1293
2024
Q3 		$447 Buy
+3
New +$430 ﹤0.01% 1365
2024
Q2 		– Sell
-6
Closed -$1.1K – 1702
2024
Q1 		$1.1K Buy
6
+5
+500% +$952 ﹤0.01% 1003
2023
Q4 		$180 Sell
1
-3
-75% -$467 ﹤0.01% 1481
2023
Q3 		$637 Hold
4
– – ﹤0.01% 1125
2023
Q2 		$566 Hold
4
– – ﹤0.01% 1119
2023
Q1 		$674 Sell
4
-3
-43% -$535 ﹤0.01% 1039
2022
Q4 		$1.19K Buy
7
+4
+133% +$726 ﹤0.01% 863
2022
Q3 		$1K Buy
+3
New +$633 ﹤0.01% 879
2022
Q1 		$0 Buy
+1
New +$190 ﹤0.01% 1224

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

SJS Investment Consulting's RGEN Position: Q1 2026 in Review

SJS Investment Consulting sold out of Repligen (RGEN) in Q1 2026, closing a stake of 2 shares — an estimated $328 sold.

SJS Investment Consulting first reported a position in RGEN in Q1 2022 and held it in 14 quarters. The position peaked at $1.19K in Q4 2022. 443 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • SJS Investment Consulting reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • SJS Investment Consulting sold 2 Repligen shares in Q1 2026, an estimated $328.
  • SJS Investment Consulting first reported a position in Repligen in Q1 2022 and held it in 14 quarters.
  • SJS Investment Consulting's Repligen position peaked at $1.19K in Q4 2022.
  • 443 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on SJS Investment Consulting's 13F filing for Q1 2026, filed 23 Apr 2026.